Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cystic fibrosis lung inflammation: early, sustained, and severe.

Literature DB >> 7697269

Cystic fibrosis lung inflammation: early, sustained, and severe.

A Cantin.

Abstract

Entities: Disease

Mesh：

Year: 1995 PMID： 7697269 DOI： 10.1164/ajrccm.151.4.7697269

Source DB: PubMed Journal: Am J Respir Crit Care Med ISSN： 1073-449X Impact factor: 21.405

Keyword Cloud
Cited

× No keyword cloud information.

46 in total

1. CFTR is a pattern recognition molecule that extracts Pseudomonas aeruginosa LPS from the outer membrane into epithelial cells and activates NF-kappa B translocation.

Authors: Torsten H Schroeder; Martin M Lee; Patrick W Yacono; Carolyn L Cannon; A Alev Gerçeker; David E Golan; Gerald B Pier
Journal: Proc Natl Acad Sci U S A Date: 2002-05-07 Impact factor: 11.205

2. Enhanced susceptibility to pulmonary infection with Burkholderia cepacia in Cftr(-/-) mice.

Authors: U Sajjan; G Thanassoulis; V Cherapanov; A Lu; C Sjolin; B Steer; Y J Wu; O D Rotstein; G Kent; C McKerlie; J Forstner; G P Downey
Journal: Infect Immun Date: 2001-08 Impact factor: 3.441

3. Effect of nebulised recombinant DNase on neutrophil elastase load in cystic fibrosis.

Authors: C M Costello; C M O'Connor; G A Finlay; P Shiels; M X FitzGerald; J P Hayes
Journal: Thorax Date: 1996-06 Impact factor: 9.139

4. Oscillating devices for airway clearance in people with cystic fibrosis.

Authors: Lisa Morrison; Stephanie Milroy
Journal: Cochrane Database Syst Rev Date: 2020-04-30

5. Abnormalities in the pulmonary innate immune system in cystic fibrosis.

Authors: Theo J Moraes; Jonathan Plumb; Raiza Martin; Eric Vachon; Vera Cherepanov; Adeline Koh; Carola Loeve; Jenny Jongstra-Bilen; Joanna H Zurawska; Julianne V Kus; Lori L Burrows; Sergio Grinstein; Gregory P Downey
Journal: Am J Respir Cell Mol Biol Date: 2005-11-17 Impact factor: 6.914

Cystic fibrosis lung inflammation: early, sustained, and severe.

1. CFTR is a pattern recognition molecule that extracts Pseudomonas aeruginosa LPS from the outer membrane into epithelial cells and activates NF-kappa B translocation.

2. Enhanced susceptibility to pulmonary infection with Burkholderia cepacia in Cftr(-/-) mice.

3. Effect of nebulised recombinant DNase on neutrophil elastase load in cystic fibrosis.

4. Oscillating devices for airway clearance in people with cystic fibrosis.

5. Abnormalities in the pulmonary innate immune system in cystic fibrosis.

Review 6. Role of corticosteroids in cystic fibrosis lung disease.

Review 7. The role of inflammation in the pathophysiology of CF lung disease.

8. Exercise testing in patients with cystic fibrosis-importance of ventilatory parameters.

9. High-dose oral N-acetylcysteine, a glutathione prodrug, modulates inflammation in cystic fibrosis.

10. Airway clearance devices for cystic fibrosis: an evidence-based analysis.